Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1 Colorectal Adenocarcinoma 1 Cachexia 1

Interventions

testosterone enanthate 1 remune 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 bermekimab 1 alkaloid GB18 1 Pentoxifylline 1 Olanzapine 1 Fluoxetine 1 Fluorouracil 1 Exercise 1 Cannabidiol 1 Adenosine Triphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cachexia × Fluoxetine × Clear all

NCT00489593 2015-01-08

Olanzapine in Patients With Advanced Cancer and Weight Loss

M.D. Anderson Cancer Center

Phase 1 Completed

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡